
TrabTech secured new investment and research fund of €1.3 million for the development of advanced 3D-printed implant applications. With this funding, TrabTech will be able to complete the regulatory process for its new products, relocate its headquarters to Germany to enter the EU market, and prepare for FDA clearance, all while commercializing its first mass-produced product, the TrabCup hip prosthesis.
TrabTech is pioneering a series of trabecular implants using additive manufacturing. With this new funding, TrabTech will continue its research and development activities, as well as further improve the Trabecular Implant series and create new products in the orthopedic and pediatric fields. The company’s goal is to bring its products to market as soon as possible.
TrabTech also announced a new research project set to begin in 2023. In recent months, TrabTech, as the project coordinator, received approval from the European Commission for this new project. The goal of the project is to develop implant products using artificial intelligence-supported various design methods and special porous structures through a new process.
TrabTech CEO Kuntay Aktaş said, “When we first started working in this field, the ‘Additive Manufacturing’ technology and medical applications were not well-known. Today, we can see the acceptance of a technology that is set to revolutionize the implant industry. Such transformations can only be achieved through strong collaborations. We bring our developed products to life through collaborations with some of the most prestigious universities and institutions in the world. TrabTech is not an implant or orthopedic company, it’s a new-generation technology company that uses methods, tools, ways of working, and multinational company culture that goes beyond its developed products. Our collaborations with institutions in Switzerland, Germany, Sweden, the United Kingdom, and the United States are particularly exciting for us, as they reflect our vision and competence. Our goal is to be one of the world’s leading technology companies in the field of additive manufacturing.”
Source: TrabTech
JAV
Julie A. Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.